What do systematic reviews say?

10 questions · 10 findings · 4 reviews · Emergency and Critical Care

Sort:Best matchNewest Highest certainty Download CSV

No studies found 10 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Heterologous vaccination scheme vs homologous vaccination scheme

All‐cause mortalityÂ

The review found no eligible studies for this question.

1 finding from 1 review

Efficacy and safety of COVID‐19 vaccines 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of Oxford vs ChAdOx1 – University of Oxford

All‐cause mortalityÂ

The review found no eligible studies for this question.

1 finding from 1 review

Efficacy and safety of COVID‐19 vaccines 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

WIBP‐CorV – Sinopharm‐Wuhan vs placebo

All‐cause mortalityÂ

The review found no eligible studies for this question.

1 finding from 1 review

Efficacy and safety of COVID‐19 vaccines 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

BBIBP‐CorV – Sinopharm‐Beijing vs placebo

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Efficacy and safety of COVID‐19 vaccines 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

All‐cause mortality · people suffering from high altitude illness

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating acute high altitude illness 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

All‐cause mortality · people suffering from high altitude illness

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating acute high altitude illness 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Beta‐agonist vs control

Late all‐cause mortality ( > 3 months · adults with acute respiratory distress syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

N‐acetylcysteine vs control

Late all‐cause mortality ( > 3 months · adults with acute respiratory distress syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Statins vs control

Late all‐cause mortality ( > 3 months · adults with acute respiratory distress syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Olokizumab vs placebo or usual care

All‐cause mortality D60 or more · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found